ACH (Accendra Health) Risk Assessment


ACH Accendra Health Inc ACH
57 GF Score
Price $3.30
GF Value $5.01
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Accendra Health Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Accendra Health is: High Risk: High uncertainty.

Accendra Health  (NYSE:ACH) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Accendra Health Risk Assessment Related Terms

ACH vs FOCL, YI, COSM: Risk Assessment Comparison

For the Medical Distribution subindustry, Accendra Health's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accendra Health Risk Assessment vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Accendra Health's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Accendra Health's Risk Assessment falls into.


ACH
57GF Score
Accendra Health Inc ACH
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Accendra Health (ACH) Overvalued in 2026?

Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued. The current stock price of $3.30 is trading 34.1% below its estimated GF Value™ of $5.01. GuruFocus considers Accendra Health to be Possible Value Trap.

Key valuation signals for ACH:

  • Risk Assessment:
  • GF Value™: $5.01 vs. price of $3.30 (34.1% below fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Accendra Health Business Description

Other Exchanges 6OM:Germany
Address 10900 Nuckols Road, Suite 400, Glen Allen, VA, USA, 23060
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
57GF Score

Get the complete analysis for ACH

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.30
Price
$5.01
GF Value